Navigation Links
Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer
Date:12/3/2008

CHICAGO, Dec. 3 /PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI) has equivalent sensitivity and better specificity than breast MRI in patients with inconclusive findings after mammography and ultrasound in the diagnosis of breast cancer, according to findings presented today at the annual meeting of the Radiological Society of North America (RSNA). BSGI is a molecular breast imaging technique used as an adjunctive tool to mammography that can identify lesions independent of tissue density.

"The purpose of this study was to compare MRI and BSGI in women with indeterminate findings after applying mammography and ultrasound. We found BSGI has virtually equal sensitivity and better specificity than breast MRI in the diagnosis of breast cancer," said Dr. Leora Lanzkowsky.

Dr. Leora Lanzkowsky, as Medical Director of the Eisenhower Medical Center in Rancho Mirage, CA and her colleagues conducted BSGI and breast MRI on patients with complex, inconclusive mammographic and/or ultrasonic findings. In their group of 48 patients with 63 abnormalities, BSGI and MRI yielded consistent results in 37 of these areas and were inconsistent in 26. MRI was inconclusive in a greater number of benign cases -- 10 versus three on BSGI. Overall, in this group of patients with difficult to diagnose breast findings, the sensitivity of BSGI and MRI was 96 percent and 88 percent respectively; specificity was 46 percent and 27 percent respectively.

The advantages of BSGI over MRI include ease of interpretation with fewer images generated, and better tolerance of the test by patients. In addition, BSGI can be used in all patients including those with ferromagnetic implants or renal insufficiency.

BSGI for the study was conducted using a Dilon 6800 Gamma Camera, a high-resolution, small field-of-view gamma camera, optimized to perform BSGI. With BSGI, the patient receives a pharmaceutical tracing agent that is abs
'/>"/>

SOURCE Dilon Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual...v. 9 (HealthDay News) -- Researchers were able to ...nises by growing new penile tissue in the lab and ...human application is a ways off, researchers say t... erectile dysfunction in men. , "We were able t...
(Date:11/9/2009)... , Tomorrow may be too la...etes condition, according to TOPS Club, Inc. (Take...upport organization. , (V... when it comes to preventing or improving a diabet...ff Pounds Sensibly), the nonprofit weight-loss sup...
(Date:11/9/2009)... , SANTA MONICA, Calif., Nov. 9 /PRNewswire/ ... Foundation joined philosophy on Saturday to...nce support services throughout California by buil... shelters. Enough kits were created to give one t...served in one of Los Angeles County,s domestic vio...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... , NEW YORK, Nov. 9 /PRNewswire/ -- Phoen...l and drug abuse treatment and prevention program,...h.D., a nationally and internationally recognized ...as Chief Clinical Officer, effective January 1, 20...ont of substance abuse treatment research and her ...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...ients with clinically operable cervical cancer fro...retreatment imaging does not lead to increased sur...developed a decision-analytic model to determine t... Boston, and lead author of the study. What we fou...
... Stem Cell Network Annual Science Meeting in Edinb...isms normally involved in balancing different func... Her team from Barts and the London School of Med...gnant brain tumours. This work has been funded by...
...ood cell production is controlled could lead to im...anaemia, according to West Australian medical rese...s published in Blood, the journal of the American ...Research (WAIMR) Director Peter Klinken and his La...
...ry on how immune system responds to invaders , ...e system T-cells don,t begin to multiply until up ...ng that changes current thinking about how the imm...an evolutionary safeguard against the risk of an a...
...centric Medical,Inc., the global leader in devices...ay announced that Maria Sainz has been named Presi...he new appointment was effective,April 8, 2008., ... Cardiac Surgery division of Guidant Corporation a...
...ify Systems, Inc., a,real-time compression technol...amplify for Windows Release 2.6 and Samplify for W...vides the same compression and,decompression engin..., "Many of our customers in the defense and medic...
Other Medicine News:Health News:Stem cells and cancer: Scientists investigate a fine balancing act 2Health News:Twin findings raise hopes of improved anemia treatments 2Health News:T-Cell Duplication Delayed Up to 3 Days After Infection 2Health News:Maria Sainz Named President and CEO of Concentric Medical 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 3
(Date:11/9/2009)...D LASERS just announced that industry leading dent... position of Medical Director. In his new role, D...ch and development of new soft and hard tissue den...g education credits, authoring articles for relate...ng and seminar engagements. ,, "We are very for...
(Date:11/9/2009)...swire/ -- Unwavering from its pursuit of producing...,s economic climate, Lutronic, Inc., a leading dev...troduces the MOSAIC CO2, a full-featured fractiona...OSAIC CO2 offers many of the features unique to Lu...and stamping operation modes and patented Controll...
(Date:11/9/2009)...all/ -- Arcadia Resources, Inc. (NYSE Amex: KAD )... care services under the Arcadia HealthCare(SM) br...of Directors. Goldsmith will replace Tres Lund wh..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...Paul Professor of Government and Director of Innov...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Lutronic(R) Unleashes the New MOSAIC CO2 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 2Arcadia Resources Names Stephen Goldsmith to Board of Directors 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 1PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 2PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 3PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 4PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 5PTC Therapeutics Initiates Registration Directed Phase 3 Trial of Ataluren in Cystic Fibrosis 13969 6Lithium Ion Battery Maker Names New President 13967 1Lithium Ion Battery Maker Names New President 13967 2Lithium Ion Battery Maker Names New President 13967 3Lithium Ion Battery Maker Names New President 13967 4Lithium Ion Battery Maker Names New President 13967 5Lithium Ion Battery Maker Names New President 13967 6Pandemic flu can infect cells deep in the lungs says new research 9859 1Pandemic flu can infect cells deep in the lungs says new research 9859 2Pandemic flu can infect cells deep in the lungs says new research 9859 3
...etion of Phase III Trials of Light Infusion Therap...ectal Cancer and Phase I/II and Phase II... Wash., July 15 Light Sciences Oncology, Inc.,(LS...sion Therapy(TM),(Litx(TM)) to treat cancer and ot... $40.1 million in a Series C round of financing. T...
...is of the Alzheimer,s Disease Market Now Available...WALTHAM, Mass., July 15 Decision Resources, one o...for pharmaceutical and,healthcare issues, finds th...continue the development of Flurizan, the most lik...disease treatment becomes Elan/Wyeth,s,bapineuzuma...
Other Medicine Technology:Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...program offers state-of-the-art quality in an inst... strength and durability. Low profile cutting tips...Series I instruments are available in just about e...r large and small joint arthroscopic procedures.,...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
...es facilitates fast and effective resection of men...y shaped meniscal rim. The flat, crescent-shaped t... tightest joint spaces. Made in the U.S. at Arthre...ence in arthroscopy hand instrument design guarant...
Medicine Products: